Venous Thromboembolism Prophylaxis For Esophagectomy: A Survey of Practice Patterns Among Thoracic Surgeons

Annals of Thoracic Surgery

Volumn 101, Issue 2, 2016, Pages 489-494

  Zwischenberger, Brittany A ^a   Tzeng, Ching Wei D ^a   Ward, Nicholas D ^a   Zwischenberger, Joseph B ^a   Martin, Jeremiah T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

AGE; BLOOD TRANSFUSION; CANCER DIAGNOSIS; CLINICAL PRACTICE; CONFERENCE PAPER; ESOPHAGUS RESECTION; HOSPITAL DISCHARGE; HUMAN; LOW DRUG DOSE; OBESITY; OPERATION DURATION; PAIN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; THORACIC SURGEON; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRE; THORAX SURGERY;

ANTICOAGULANTS; ESOPHAGECTOMY; HEPARIN; HUMANS; POSTOPERATIVE COMPLICATIONS; PRACTICE PATTERNS, PHYSICIANS'; SURVEYS AND QUESTIONNAIRES; THORACIC SURGERY; VENOUS THROMBOEMBOLISM;

EID: 84974799162     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.07.023     Document Type: Conference Paper

References (31)

1. 1 Bergqvist, D., Agnelli, G., Cohen, A.T., et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346 (2002), 975–980.
2. 2 Blom, J.W., Vanderschoot, J.P., Oostindier, M.J., Osanto, S., van der Meer, F.J., Rosendaal, F.R., Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4 (2006), 529–535.
3. 3 Gould, M.K., Garcia, D.A., Wren, S.M., et al. American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:2 Suppl (2012), e227S–e277S.
4. 4 Leonardi, M.J., McGory, M.L., Ko, C.Y., A systematic review of deep venous thrombosis prophylaxis in cancer patients: Implications for improving quality. Ann Surg Oncol 14 (2007), 929–936.
5. 5 Mismetti, P., Laporte, S., Darmon, J.Y., Buchmuller, A., Decousus, H., Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88 (2001), 913–930.
6. 6 Collins, R., Scrimgeour, A., Yusuf, S., Peto, R., Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 318 (1988), 1162–1173.
7. 7 Blom, J.W., Doggen, C.J., Osanto, S., Rosendaal, F.R., Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293 (2005), 715–722.
8. 8 Martin, J.T., Mahan, A., Ferraris, V.A., et al. Identifying esophagectomy patients at risk for pre- versus post-discharge venous thromboembolism. Ann Thorac Surg, 2015 [Epub ahead of print] http://dx.doi.org/10.1016/j.athoracsur.2015.04.042.
9. 9 De Martino, R.R., Goodney, P.P., Spangler, E.L., et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg 55 (2012), 1035–1040 e1034.
10. 10 Mukherjee, D., Lidor, A.O., Chu, K.M., Gearhart, S.L., Haut, E.R., Chang, D.C., Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg 12 (2008), 2015–2022.
11. 11 Trinh, V.Q., Karakiewicz, P.I., Sammon, J., et al. Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. JAMA Surg 149 (2014), 43–49.
12. 12 Agnelli, G., Bolis, G., Capussotti, L., et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery. Ann Surg 243 (2006), 89–95.
13. 13 Farge, D., Debourdeau, P., Beckers, M., et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 11 (2013), 56–70.
14. 14 National Comprehensive Cancer Network. Venous thromboembolic disease (version 2.2014) Available at: http://www.nccn.org/professionals/physician_gls/pdf/vte.pdf. Accessed February 27, 2015.
15. 15 Weiss, M.J., Kim, Y., Ejaz, A., et al. Venous thromboembolic prophylaxis after a hepatic resection: Patterns of care among liver surgeons. HPB (Oxford) 16 (2014), 892–898.
16. 16 Merkow, R.P., Bilimoria, K.Y., McCarter, M.D., et al. Post-discharge venous thromboembolism after cancer surgery: Extending the case for extended prophylaxis. Ann Surg 254 (2011), 131–137.
17. 17 Kakkar, V.V., Balibrea, J.L., Martinez-Gonzalez, J., Prandoni, P., Group, C.S., Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost 8 (2010), 1223–1229.
18. 18 Rasmussen, M., Jorgensen, L., Wille-Jorgensen, P., et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 4 (2006), 2384–2390.
19. 19 Findlay, J.M., Gillies, R.S., Millo, J., Sgromo, B., Marshall, R.E., Maynard, N.D., Enhanced recovery for esophagectomy: a systematic review and evidence-based guidelines. Ann Surg 259 (2014), 413–431.
20. 20 Byrne, M., Reynolds, J.V., O'Donnell, J.S., et al. Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer 102 (2010), 73–79.
21. 21 Verhage, R.J., van der Horst, S., van der Sluis, P.C., Lolkema, M.P., van Hillegersberg, R., Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma. Ann Surg Oncol 19 (2012), 684–692.
22. 22 Bosch, D.J., Van Dalfsen, Q.A., Mul, V.E., Hospers, G.A., Plukker, J.T., Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. Am J Surg 208 (2014), 215–221.
23. 23 Bakirhan, K., Strakhan, M., Pharmacologic prevention of venous thromboembolism in obese patients. J Thromb Thrombolysis 36 (2013), 247–257.
24. 24 Akl, E.A., Terrenato, I., Barba, M., et al. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. Arch Intern Med 168 (2008), 1261–1269.
25. 25 King, C.S., Holley, A.B., Jackson, J.L., Shorr, A.F., Moores, L.K., Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: a metaanalysis. Chest 131 (2007), 507–516.
26. 26 Magee, C.J., Barry, J., Javed, S., Macadam, R., Kerrigan, D., Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery. Surg Obes Relat Dis 6 (2010), 322–325.
27. 27 Borkgren-Okonek, M.J., Hart, R.W., Pantano, J.E., et al. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis 4 (2008), 625–631.
28. 28 Shah, D.R., Wang, H., Bold, R.J., et al. Nomograms to predict risk of in-hospital and post-discharge venous thromboembolism after abdominal and thoracic surgery: an American College Of Surgeons National Surgical Quality Improvement Program Analysis. J Surg Res 183 (2013), 462–471.
29. 29 Horlocker, T.T., Wedel, D.J., Rowlingson, J.C., et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy. Reg Anesth Pain Med 35 (2010), 64–101.
30. 30 Gustafsson, U.O., Scott, M.J., Schwenk, W., et al. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Clin Nutr 31 (2012), 783–800.
31. 31 Pashikanti, L., Von Ah, D., Impact of early mobilization protocol on the medical-surgical inpatient population: an integrated review of literature. Clin Nurse Spec 26 (2012), 87–94.